SAB Biotherapeutics (SABS) Current Assets (2020 - 2026)
SAB Biotherapeutics' Current Assets came in at $107.94 million for Q2 2026, compared with $9.31 million a year earlier and down 4.3% from the prior quarter.
Powered by 
Analysis
SAB Biotherapeutics (SABS) Current Assets (2020 - 2026) Analysis & Trends
At the end of FY2025, SAB Biotherapeutics' Current Assets was $101.05 million, up 324.7% from FY2024.
- Current Assets carries a five-year compound annual growth rate of 24.0% (FY2020 to FY2025).
- Going back by year, Current Assets was $23.79 million in FY2024 (-59.6%), $58.91 million in FY2023 (+166.6%), $22.1 million in FY2022 (-56.0%) and $50.19 million in FY2021 (+45.7%).
- The five-year range for quarterly Current Assets is $770,615 (Q3 2021) to $113.28 million (Q3 2025).
- Year-over-year, Current Assets increased in four of the last seven quarters, with growth averaging 272.0%.
- The fastest year-over-year change in Current Assets over five years came in Q3 2024 (growth of 940.3%), and the weakest in Q3 2023 (a decline of 85.9%).
- Business Quant data shows SABS's Current Assets at $112.78 million (Q1 2026), $101.05 million (Q4 2025) and $113.28 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 27.97 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.96 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 13.95 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 41.36 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 12.54 Bn |
| 10 | SAB Biotherapeutics | 268.01 Mn | 268.01 Mn | - | 107.94 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 107.94 Mn |
| Mar 31, 2026 | 112.78 Mn |
| Dec 31, 2025 | 101.05 Mn |
| Sep 30, 2025 | 113.28 Mn |
| Jun 30, 2025 | 9.31 Mn |
| Mar 31, 2025 | 16.30 Mn |
| Dec 31, 2024 | 23.79 Mn |
| Sep 30, 2024 | 32.54 Mn |
| Jun 30, 2024 | 39.58 Mn |
| Mar 31, 2024 | 46.95 Mn |
| Dec 31, 2023 | 58.91 Mn |
| Sep 30, 2023 | 3.13 Mn |
| Jun 30, 2023 | 9.01 Mn |
| Mar 31, 2023 | 15.03 Mn |
| Dec 31, 2022 | 22.10 Mn |
| Sep 30, 2022 | 22.18 Mn |
| Jun 30, 2022 | 28.00 Mn |
| Mar 31, 2022 | 37.18 Mn |
| Dec 31, 2021 | 50.19 Mn |
| Sep 30, 2021 | 770,615.00 |
API Access
SAB Biotherapeutics Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=SABS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "SABS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=SABS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();